Download PDF
CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2016; 74(12): 999-1002
DOI: 10.1590/0004-282X20160153
ARTICLE

Migraine in the post-menopausal period is associated with higher levels of mood disorders, disability, and more menopausal symptoms

Migrânea no período pós-menopausal se associa a maiores índices de alterações do humor, de incapacidade e de sintomas de menopausa
Paula Carturan
1   Universidade Metropolitana de Santos, Departamento de Ginecologia e Obstetrícia, Santos SP, Brasil;
,
Claudio Scorcine
2   Universidade Metropolitana de Santos, Faculdade de Educação Física, Santos SP, Brasil;
,
Yara Dadalti Fragoso
3   Universidade Metropolitana de Santos, Departamento de Neurologia, Santos SP, Brasil.
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

ABSTRACT

Objective

To assess the prevalence of headache in post-menopausal women.

Methods

Women attending gynecology outpatient services in the coastal region of the state of Sao Paulo, Brazil were invited to participate in this study. Only those with non-surgical menopause and no hormone replacement therapy were included. Prevalence and characterization of headaches were assessed, as well as the burden of migraine, traits of anxiety and depression, and menopausal symptomatology.

Results

One hundred and three women were included in the study. Migraine affected 14.7% of them. Some previous type of headache was reported by 86.2% of the women, most of whom improved during menopause but still presented with headache attacks. There was a correlation between higher migraine disability and depressive traits.

Conclusions

Many women believe that their headaches, particularly migraine, will end after menopause. This is, unfortunately, not the case for many of them.

RESUMO

Objetivo

Avaliar a prevalência de cefaleia em mulheres no período pós-menopausal.

Métodos

Mulheres atendidas em serviços de ginecologia na região costeira do estado de São Paulo, Brasil foram convidadas a participar deste estudo. Apenas mulheres com menopausa não-cirúrgica e sem terapia de reposição hormonal foram incluídas. Foram avaliados prevalência e características das cefaleias, incapacidade por enxaqueca, traços de ansiedade e depressão e sintomatologia menopausal.

Resultados

Centro e três mulheres foram incluídas neste estudo. Enxaqueca afetava 14,7% delas. Antecedente de algum tipo de dor de cabeça foi relatada por 86,2% das mulheres, a maioria das quais melhorou durante a menopausa, mas ainda apresentava crises. Houve correlação entre maior incapacidade por enxaqueca e traço depressivo.

Conclusão

Muitas mulheres acreditam que suas cefaleias, particularmente enxaqueca, terminarão quando começar a menopausa. Este, infelizmente, não é o caso para muitas delas.

headache - migraine disorders - menopause - women
cefaleia - transtornos de enxaqueca - menopausa - mulheres


Publication History

Received: 05 June 2016

Accepted: 14 September 2016

Article published online:
06 September 2023

© 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Brandes JL. Migraine in women. Continuum (Minneap Minn). 2012;18(4):835-52. doi:10.1212/01.CON.0000418646.70149.71
  • 2 Chai NC, Peterlin BL, Calhoun AH. Migraine and estrogen. Curr Opin Neurol. 2014;27(3):315-24. doi:10.1097/WCO.20160153201601530091
  • 3 Ripa P, Ornello R, Degan D, Tiseo C, Stewart J, Pistoia F et al. Migraine in menopausal women: a systematic review. Int J Womens Health. 2015;7:773-82. doi:10.2147/IJWH.S70073
  • 4 Mattsson P. Hormonal factors in migraine: a population-based study of women aged 40 to 74 years. Headache. 2003;43(1):27-35. doi:10.1046/j.1526-4610.2003.03005.x
  • 5 Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S. Symptoms in the menopausal transition: hormone and behavioral correlates. Obstet Gynecol. 2008;111(1):127-36. doi:10.1097/01.AOG.0000295867.06184.b1
  • 6 Sabia S, Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Risk factors for onset of menopausal symptoms: results from a large cohort study. Maturitas. 2008;60(2):108-21. doi:10.1016/j.maturitas.2008.04.004
  • 7 Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70. doi:10.1111/j.1600-0447.1983.tb09716.x
  • 8 Hauser GA, Huber IC, Keller PJ, Lauritzen C, Schneider HP. [Evaluation of climacteric symptoms (Menopause Rating Scale)[. Zentralbl Gynakol. 1994;116:16-23. German.
  • 9 International Headache Society. The international classification of headache disorders. 2nd ed. London: International Headache Society; 2004. Cephalalgia. Suppl 1:9-160.
  • 10 Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2001;41(9):854-61. doi:10.1046/j.1526-4610.2001.01156.x
  • 11 Fragoso YD. MIDAS (Migraine Disability Assessment): a valuable tool for work-site identification of migraine in workers in Brazil. Sao Paulo Med J. 2002;120(4):118-21. doi:10.1590/S1516-31802002000400006
  • 12 Banister EM. Women’s midlife confusion: “why am I feeling this way?” Issues Ment Health Nurs. 2000;21(8):745-64. doi:10.1080/016128400750044251
  • 13 Pearce G, Thøgersen-Ntoumani C, Duda J. Body image during the menopausal transition: a systematic scoping review. Health Psychol Rev. 2014;8(4):473-89. doi:10.1080/17437199.2013.848408
  • 14 Reid R, Abramson BL, Blake J, Desindes S, Dodin S, Johnston S et al. Managing menopause. J Obstet Gynaecol Can. 2014;36(9):830-8. doi:10.1016/S1701-2163(15)30487-4
  • 15 Bordini CA, Roesler C, Carvalho DS, Macedo DDP, Piovesan E, Melhado EM, et al. Recommendations for the treatment of migraine attacks: a Brazilian consensus. Arq Neuropsiquiatr 2016;74(3):262-71. doi:10.1590/0004-282X2015021
  • 16 Queiroz LP, Silva Junior A. The prevalence and impact of headache in Brazil. Headache. 2015;55 Suppl 1:32-38. doi:10.1111/head.12511